These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 14732849)

  • 1. [Epidemiology and management of care of hepatitis C infection in the Poitou-Charentes region in 1997 and 2000].
    Blanchet E; Defossez G; Verneau A; Ingrand I; Silvain C; Beauchant M;
    Gastroenterol Clin Biol; 2003 Nov; 27(11):1026-30. PubMed ID: 14732849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hepatitis C virus infection in the Poitou- Charentes region].
    Frère T; Verneau A; Besson I; de Bayser L; Dupuychaffray JP; Kitmacher P; Silvain C; Beauchant M
    Gastroenterol Clin Biol; 1999; 23(8-9):887-91. PubMed ID: 10533141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening and hepatitis C management survey in general medicine in the Alpes-Maritimes and east Var area].
    Ouzan D; Hofliger P; Cavailler P; Mamino C; Tran A
    Gastroenterol Clin Biol; 2003 Jan; 27(1):90-3. PubMed ID: 12594371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region].
    Bonny C; Rayssiguier R; Ughetto S; Aublet-Cuvelier B; Baranger J; Blanchet G; Delteil J; Hautefeuille P; Lapalus F; Montanier P; Bommelaer G; Abergel A
    Gastroenterol Clin Biol; 2003 Nov; 27(11):1021-5. PubMed ID: 14732848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C epidemiology at a general hospital center. Management and natural history as a function of the manner of identification].
    Cadranel JF; Di Martino V; Cesbron H; Cazier A; Demontis R; Coutarel P; Bachmeyer C; Cordier F; Lukumbo S; Fiévet P; Mougeot-Martin M; Van Batten C; Devergie B; Dumouchel P
    Gastroenterol Clin Biol; 2000 Feb; 24(2):161-7. PubMed ID: 12687956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristics of patients with hepatitis C virus antibodies followed in specialized university hospital units are different from those of patients in the general population. The Research Group of the REBOHC].
    Goegebeur G; Benhamiche AM; Minello A; Rassiat E; Clinard F; Milan C; Faivre J; Hillon P
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1042-6. PubMed ID: 11139673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
    Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
    Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of HCV infection in the general population: a survey in a southern Italian town.
    Cozzolongo R; Osella AR; Elba S; Petruzzi J; Buongiorno G; Giannuzzi V; Leone G; Bonfiglio C; Lanzilotta E; Manghisi OG; Leandro G; ; Donnaloia R; Fanelli V; Mirizzi F; Parziale L; Crupi G; Detomaso P; Labbate A; Zizzari S; Depalma M; Polignano A; Lopinto D; Daprile G
    Am J Gastroenterol; 2009 Nov; 104(11):2740-6. PubMed ID: 19638964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receiving a hepatitis C-positive diagnosis.
    Hopwood M; Treloar C
    Intern Med J; 2004; 34(9-10):526-31. PubMed ID: 15482264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a hepatitis C screening tool in primary care.
    McGinn T; O'Connor-Moore N; Alfandre D; Gardenier D; Wisnivesky J
    Arch Intern Med; 2008 Oct; 168(18):2009-13. PubMed ID: 18852403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.
    López RA; Romero-Estrella S; Infante-Ramírez L; Méndez-Aquino JS; Berrón-Ruiz P; Morales-Alfaro NA; Vivar R; Carrada E; Rivera-Rendón Mdel R; Sánchez-Guerrero SA
    Transfusion; 2004 Sep; 44(9):1344-9. PubMed ID: 15318859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Organized hepatitis C screening. Results and cost of a one-year campaign in a pilot area].
    Monnet E; Mercet P; Woronoff-Lemsi MC; Bresson-Hadni S; Pruniaux J; Cottray P; Bouiller C; Allemand H; Miguet JP
    Gastroenterol Clin Biol; 2000 May; 24(5):541-6. PubMed ID: 10891743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients.
    Choy Y; Gittens-Williams L; Apuzzio J; Skurnick J; Zollicoffer C; McGovern PG
    Infect Dis Obstet Gynecol; 2003; 11(4):191-8. PubMed ID: 15108864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain.
    Martínez-Bauer E; Forns X; Armelles M; Planas R; Solà R; Vergara M; Fàbregas S; Vega R; Salmerón J; Diago M; Sánchez-Tapias JM; Bruguera M;
    J Hepatol; 2008 Jan; 48(1):20-7. PubMed ID: 17998149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and proposal of a new combination of screening criteria for hepatitis C in France.
    King LA; Le Strat Y; Meffre C; Delarocque-Astagneau E; Desenclos JC
    Eur J Public Health; 2009 Oct; 19(5):527-33. PubMed ID: 19667051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of a new hepatitis C risk assessment tool.
    Nguyen MT; Herrine SK; Laine CA; Ruth K; Weinberg DS
    Arch Intern Med; 2005 Sep; 165(17):2013-8. PubMed ID: 16186472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.
    Payan C; Roudot-Thoraval F; Marcellin P; Bled N; Duverlie G; Fouchard-Hubert I; Trimoulet P; Couzigou P; Cointe D; Chaput C; Henquell C; Abergel A; Pawlotsky JM; Hezode C; Coudé M; Blanchi A; Alain S; Loustaud-Ratti V; Chevallier P; Trepo C; Gerolami V; Portal I; Halfon P; Bourlière M; Bogard M; Plouvier E; Laffont C; Agius G; Silvain C; Brodard V; Thiefin G; Buffet-Janvresse C; Riachi G; Grattard F; Bourlet T; Stoll-Keller F; Doffoel M; Izopet J; Barange K; Martinot-Peignoux M; Branger M; Rosenberg A; Sogni P; Chaix ML; Pol S; Thibault V; Opolon P; Charrois A; Serfaty L; Fouqueray B; Grange JD; Lefrère JJ; Lunel-Fabiani F
    J Viral Hepat; 2005 Jul; 12(4):405-13. PubMed ID: 15985012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment.
    Posthouwer D; Plug I; van der Bom JG; Fischer K; Rosendaal FR; Mauser-Bunschoten EP
    Haemophilia; 2005 May; 11(3):270-5. PubMed ID: 15876273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.